Primary Health care center Jakobsgårdarna
Borlänge, Dalarna County, 87110, Sweden
NCT Number: NCT02922803
Somali migrant women, often in veiled clothing, living in a town in mid Sweden on the 60:th parallel were observed to be weak and to have a waddling gate.
Study 1 was carried out in the setting of an antenatal clinic administered from a primary care center in Borlänge, a Swedish middle-sized industrial town at the 60:th parallel in Sweden. The investigators chose an initial study period in late spring to reflect the effects of the dark season with little ultraviolet B radiation that affects vitamin D production. Study 1 was carried out in a short period of time. The recruitment was performed in a retrospective design in order to neglect the seasonal effects of ultraviolet B radiation. Study 1 was carried out in year 2010. It was a cross sectional baseline study of blood levels of vitamin D measured as 25-hydroxyvitamin D (25-OHD) and physical performance in 123 pregnant and new mothers from Somalia (n=52) and Sweden (n=71).
Study 2: Examines the results on muscular performance, i.e. grip strength and squatting ability, from intervention with advice and prescription of vitamin D3 and calcium for 10 months, in all the women from study 1 with 25-OHD levels <50 nmol/L or 50 nmol/L of 25-OHD.
Study 3: The recruitment to Study 1 also serves as recruitment for a cohort study on delivery outcome in birth protocols starting 2016.
Study 4: The aim is to study the emic perspective and lifestyle related to vitamin D and strength in the group of Somali women by focus interviews among the Somali women from above.
A possible fifth study will explore correlations between 25-OHD and pain distribution and pain parameters.
Looking for future studies?
Notify Me18 year–50 year
Female
Interventional
Not applicable
Borlänge, Dalarna County, 87110, Sweden
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Combination tablet of Cholecalciferol (800 IU or 20 ug) and calcium carbonate (500 mg)
Other names: 1 tablet Kalcipos D Forte
Combination tablets of Cholecalciferol (800 IU or 20 ug) and calcium carbonate (500 mg)
Other names: 2 tablets Kalcipos D Forte
Time frame: 10 months
Time frame: 10 months
Time frame: 10 months
Time frame: 10 months
Time frame: 10 months
Time frame: 10 months
Uppsala University
Other
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07275177
Age-Related Loss of Skeletal Muscle Mass, Aging
Miahuatlán de Porfirio Díaz, Oaxaca, Mexico
View Trial DetailsNCT05956964
Mental Disorders, Muscle Weakness
Lexington, Kentucky, United States
View Trial DetailsNCT06216015
Chronic Disease, Chronic Kidney Failure
View Trial DetailsNCT07555782
Anterior Cruciate Ligament Injuries, Anterior Cruciate Ligament Rupture
Ataşehir, Istanbul, Turkey (Türkiye)
View Trial Details